Antigen-specific human polyclonal antibodies from hyperimmunized cattle

Nature Biotechnology

Volumn 27, Issue 2, 2009, Pages 173-181

  Kuroiwa, Yoshimi ^a,b   Kasinathan, Poothappillai ^a   Sathiyaseelan, Thillainayagen ^a   Jiao, Jin An ^a   Matsushita, Hiroaki ^a   Sathiyaseelan, Janaki ^a   Wu, Hua ^a   Mellquist, Jenny ^a   Hammitt, Melissa ^a   Koster, Julie ^a   Kamoda, Satoru ^b   Tachibana, Katsumi ^b   Ishida, Isao ^b   Robl, James M ^a  

^a Hematech Incorporated   (United States)

^b KYOWA HAKKO KOGYO CO LTD   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

HUMAN ARTIFICIAL CHROMOSOMES; HUMAN DISEASE; HUMAN IMMUNOGLOBULINS; HUMORAL IMMUNE RESPONSE; IN-VITRO; IN-VIVO; LIGHT CHAINS; POLYCLONAL ANTIBODIES; PROTECTIVE ANTIGENS; THERAPEUTIC APPLICATIONS; TRANSGENIC MOUSE;

ANTIGENS; CELL CULTURE; NORMAL DISTRIBUTION; TECHNETIUM;

ANTIBODIES;

ANTHRAX VACCINE; HYPERIMMUNE GLOBULIN; IMMUNOGLOBULIN G; IMMUNOGLOBULIN HEAVY CHAIN; POLYCLONAL ANTIBODY;

ANTIGEN SPECIFICITY; ARTICLE; ARTIFICIAL CHROMOSOME; CATTLE; FIBROBLAST; HUMAN; HUMAN CHROMOSOME; HUMORAL IMMUNITY; IMMUNE RESPONSE; IMMUNIZATION; IN VITRO STUDY; LIGHT CHAIN; NONHUMAN; PRIORITY JOURNAL; TRANSGENIC MOUSE;

ANIMALS; ANIMALS, GENETICALLY MODIFIED; ANTIGENS, BACTERIAL; BACTERIAL TOXINS; CATTLE; CHO CELLS; CHROMOSOMES, ARTIFICIAL, HUMAN; CRICETINAE; CRICETULUS; GENE KNOCKOUT TECHNIQUES; GLYCOSYLATION; HUMANS; IMMUNOGLOBULIN G; IMMUNOGLOBULIN HEAVY CHAINS; IMMUNOGLOBULIN KAPPA-CHAINS; MICE; NEUTRALIZATION TESTS; RECOMBINANT FUSION PROTEINS;

ANIMALIA; BOS; BOVINAE; MUS MUSCULUS;

EID: 59849097833     PISSN: 10870156     EISSN: 15461696     Source Type: Journal    
DOI: 10.1038/nbt.1521     Document Type: Article

References (39)

1. Lemieux, R., Bazin, R. & Neron, S. Therapeutic intravenous immunoglobulins. Mol. Immunol. 42, 839-848 (2005).
2. Jolles, S., Sewell, W.A.C. & Misbah, S.A. Clinical uses of intravenous immunoglobulin. Clin. Exp. Immunol. 142, 1-11 (2005).
3. Newcombe, C. & Newcombe, A.R. Antibody production: polyclonal-derived biotherapeutics. J. Chromatogr. B Analyt. Technol. Biomed. Life Sci. 848, 2-7 (2007).
4. Lonberg, N. Human antibodies from transgenic animals. Nat. Biotechnol. 23, 1117-1125 (2005).
5. Waltz, E. Polyclonal antibodies step out of the shadows. Nat. Biotechnol. 24, 1181 (2006).
6. Kuroiwa, Y. et al. Cloned transchromosomic calves producing human immunoglobulin. Nat. Biotechnol. 20, 889-894 (2002).
7. Kitamura, D., Roes, J., Kuhn, R. & Rajewsky, K.A. B cell-deficient mouse by targeted disruption of the membrane exon of the immunoglobulin m chain gene. Nature 350, 423-426 (1991).
8. Tomizuka, K. et al. Double trans-chromosomic mice: Maintenance of two individual human chromosome fragments containing Ig heavy and κ loci and expression of fully human antibodies. Proc. Natl. Acad. Sci. USA 97, 722-727 (2000).
9. Yel, L. et al. Mutations in the mu heavy chain gene in patients with agammaglobulinemia. N. Engl. J. Med. 335, 1486-1493 (1996).
10. Hayes, H.C. & Petit, J.E. Mapping of the β-lactoglobulin gene and of immunoglobulin M heavy chain-like sequence to homologous cattle, sheep and goat chromosomes. Mamm. Genome 4, 207-210 (1993).
11. H locus contribute to the Ig repertoire. Int. Immunol. 16, 843-852 (2004).
12. Chowdhary, B.P., Fronicke, L., Gustavsson, I. & Scherthan, H. Comparative analysis of the cattle and human genomes: detection of ZOO-FISH and gene mapping-based chromosomal homologies. Mamm. Genome 7, 297-302 (1996).
13. Tobin-Janzen, T.C. & Womack, J.E. Comparative mapping of IGHG1, IGHM, FES and FOS in domestic cattle. Immunogenetics 36, 157-165 (1992).
14. Gu, F., Chowdhary, B.P., Andersson, L., Harbitz, I. & Gustavsson, I. Assignment of the bovine immunoglobulin gamma heavy chain (IGHG) gene to chromosome 21q24 by in situ hybridization. Hereditas 117, 237-240 (1992).
15. Zhao, Y., Kacskovics, I., Rabbani, H. & Hammarstrom, L. Physical mapping of the bovine immunoglobulin heavy chain constant region gene locus. J. Biol. Chem. 278, 35024-35032 (2003).
16. Reynaud, C.A., Mackay, C.R., Muller, R.G. & Weill, J.-C. Somaticgeneration of diversity in a mammalian primary lymphoid organ: the sheep ileal Peyer's patches. Cell 64, 995-1005 (1991).
17. Jenne, C.N., Kennedy, L.J., McCullagh, P. & Reynolds, J.D. A new model of sheep Ig diversification: shifting the emphasis toward combinatorial mechanisms and away from hypermutation. J. Immunol. 170, 3739-3750 (2003).
18. Butler, J.E. Immunoglobulin diversity, B-cell and antibody repertoire development in large farm animals. Rev. Sci. Tech. 17, 43-70 (1998).
19. Butler, J.E. Immunological diversity, B-cell and antibody repertoire development in large farm animals. Rev. Sci. Tech. 17, 43-70 (1998).
20. Meyer, A. et al. Immunoglobulin gene diversification in cattle. Int. Rev. Immunol. 15, 165-183 (1997).
21. Aitken, R. et al. Structure and diversification of the bovine immunoglobulin repertoire. Vet. Immunol. Immunopathol. 72, 21-29 (1999).
22. Lucier, M.R. et al. Multiple sites of Vλ diversification in cattle. J. Immunol. 161, 5438-5444 (1998).
23. Kuroiwa, Y. et al. Sequential targeting of the genes encoding immunoglobulin-μ and prion protein in cattle. Nat. Genet. 36, 775-780 (2004).
24. Alt, F.W., Blackwell, T.K. & Yancopoulos, G.D. Development of the primary antibody repertoire. Science 238, 1079-1087 (1987).
25. Hood, L., Gray, W.R., Sanders, B.G. & Dreyer, W.Y. Light chain evolution: antibodies. Cold Spring Harbor Symp. Quan. Bio. 32, 133-146 (1967).
26. Kuroiwa, Y. et al. Manipulation of human minichromosomes to carry greater than megabase-sized chromosome inserts. Nat. Biotechnol. 18, 1086-1090 (2000).
27. Brey, R.N. Molecular basis for improved anthrax vaccines. Adv. Drug Deliv. Rev. 57, 1266-1292 (2005).
28. Raju, T.S., Briggs, B.J., Borge, M.S. & Jones, J.S.A. Species-specific variation in glycosylation of IgG: evidence for species-specific sialylation and branch-specific galactosylation and importance for engineering recombinant glycoprotein therapeutics. Glycobiology 10, 477-486 (2000).
29. Hering, D., Thompson, W., Hewetson, J., Little, S., Norris, S. & Pace-Templeton, J. Validation of the anthrax lethal toxin neutralization assay. Biologicals 32, 17-27 (2004).
30. Pittman, P.R., Parker, & Friedlander, A.M. Anthrax vaccine: immunogenicity and safety of a dose-reduction, route-change comparison study in humans. Vaccine 20, 1412-1420 (2002).
31. Semenova, V.A. et al. Mass value assignment of total and subclass immunoglobulin G in a human standard anthrax reference serum. Clin. Diagn. Lab. Immunol. 11, 919-923 (2004).
32. Wakayama, T. et al. Cloning of mice to six generations. Nature 407, 318-319 (2000).
33. Kubota, C., Tian, X.C. & Yang, X. Serial bull cloning by somatic cell nuclear transfer. Nat. Biotechnol. 22, 693-694 (2004).
34. Mann, M.R. et al. Disruption of imprinted gene methylation and expression in cloned preimplantation stage mouse embryos. Biol. Reprod. 69, 902-914 (2003).
35. Rideout, W.M., Eggan, K. & Jaenisch, R. Nuclear cloning and epigenetic reprogramming of the genome. Science 293, 1093-1098 (2001).
36. Tamashiro, K.L. et al. Cloned mice have an obese phenotype not transmitted to their offspring. Nat. Med. 8, 262-267 (2002).
37. Knight, K.L., Kingzette, M., Crane, M.A. & Zhai, S.K. Transchromosomally derived Ig heavy chains. J. Immunol. 155, 684-691 (1995).
38. Nolan-Willard, M., Berton, M.T. & Tucker, P. Coexpression of mu and gamma 1 heavy chains can occur by a discontinuous transcription mechanism from the same unrearranged chromosome. Proc. Natl. Acad. Sci. USA 89, 1234-1238 (1992).
39. Kamoda, S., Ishikawa, R. & Kakehi, K. Capillary electrophoresis with laser-induced fluorescence detection for detailed studies on N-linked oligosaccharide profile of therapeutic recombinant monoclonal antibodies. J. Chromatogr. A. 1133, 332-339 (2006).